Related Experiment Video
Updated: Nov 13, 2025

Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
Venous thrombosis in neonates
Mihir D Bhatt1, Anthony Kc Chan1
1Division of Pediatric Hematology/Oncology, Department of Pediatrics, McMaster Children's Hospital, McMaster University, Hamilton, ON, Canada.
Insights
Neonatal thrombosis incidence is rising, particularly in intensive care units. More research is needed on anticoagulation therapy for conditions like cerebral sinovenous thrombosis.
Area of Science:
- Pediatric Hematology
- Neonatal Intensive Care
- Thrombotic Disorders
Background:
- The incidence of thrombotic disorders in neonates and children is increasing.
- Neonates face a higher risk of thrombosis due to their developing coagulation system and intensive care needs.
- Advances in diagnostics and supportive care contribute to increased identification of these conditions.
Purpose of the Study:
- To review recent advances (last 3 years) in neonatal thrombosis.
- To focus on epidemiology, cerebral sinovenous thrombosis (CSVT), renal vein thrombosis (RVT), and portal vein thrombosis (PVT).
- To highlight international efforts to improve evidence for managing neonatal thrombotic events.
Main Methods:
- Review of contemporary literature on neonatal thrombosis.
- Analysis of epidemiological data from recent studies.
- Discussion of ongoing international research initiatives.
Main Results:
- Contemporary incidence of neonatal thrombosis is 6.9-15 per 1,000 NICU admissions, higher than previous reports.
- Most recent studies are small, retrospective, and single-centered.
- There is a recognized need for robust data on anticoagulation therapy (ACT) for CSVT, RVT, and PVT.
Conclusions:
- International collaborations like the International Pediatric Thrombosis Network (IPTN) and International Pediatric Stroke Study (IPSS) are crucial for advancing research.
- Further evidence is required to establish the efficacy and safety of ACT in neonatal thrombosis management.
- The findings underscore the need for larger, multicenter studies and clinical trials.
Abstract:
The incidence of thrombotic disorders in neonates and children is increasing with advances in diagnostic modalities, supportive care, and management of many health conditions. The developing coagulation system, need for intensive care, including catheterization, and co-morbid conditions are responsible for the relatively high risk of thrombosis in neonates compared to older children. This review addresses the advances over the last 3 years in neonatal thrombosis, with a focus on epidemiology, cerebral sinovenous thrombosis (CSVT), renal vein thrombosis (RVT), and portal vein thrombosis (PVT). The incidence of neonatal thrombosis in the contemporary era is reported to be 6.9-15 per 1,000 neonatal intensive care unit (NICU) admissions, compared to 2.4 per 1,000 NICU admissions reported in older registry data. The majority of recently published studies are small, retrospective, and from single centers, albeit they emphasize the need for definitive data to support the efficacy and safety of anticoagulation therapy (ACT) in the management of CSVT, RVT, and PVT. We highlight two important international initiatives geared towards improving the evidence base for these conditions. The International Pediatric Thrombosis Network (IPTN) is a collaboration of 74 centers across 27 countries (as of January 2021) which has started important projects like the international neonatal RVT registry, while the International Pediatric Stroke Study (IPSS) group is in the planning stages of a randomized controlled trial to evaluate the utility of ACT in the management of neonatal CSVT.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis IV: Nursing Management
Fetal Circulation
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Varicose Veins I: Introduction

